Advertisement
CRRTF vs ECGS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRRTF is a Hold and ECGS is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CRRTF’s FA Score shows that 0 FA rating(s) are green whileECGS’s FA Score has 0 green FA rating(s).
- CRRTF’s FA Score: 0 green, 5 red.
- ECGS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CRRTF’s TA Score shows that 4 TA indicator(s) are bullish while ECGS’s TA Score has 4 bullish TA indicator(s).
- CRRTF’s TA Score: 4 bullish, 4 bearish.
- ECGS’s TA Score: 4 bullish, 5 bearish.
Price Growth
CRRTF (@Pharmaceuticals: Generic) experienced а +3.66% price change this week, while ECGS (@Tobacco) price change was +50.50% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +60.17%. For the same industry, the average monthly price growth was +10.17%, and the average quarterly price growth was +74.80%.
The average weekly price growth across all stocks in the @Tobacco industry was +4.49%. For the same industry, the average monthly price growth was +10.86%, and the average quarterly price growth was +16.64%.
Industries' Descriptions
@Pharmaceuticals: Generic (+60.17% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
@Tobacco (+4.49% weekly)The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.
| CRRTF | ECGS | CRRTF / ECGS | |
| Capitalization | 6.26M | 9.43M | 66% |
| EBITDA | 91K | N/A | - |
| Gain YTD | -19.822 | 330.000 | -6% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 20.3M | N/A | - |
| Total Cash | 8.18M | N/A | - |
| Total Debt | 602K | N/A | - |
CRRTF | ECGS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 98 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 57 Fair valued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 80 | |
SMR RATING 1..100 | 94 | 100 | |
PRICE GROWTH RATING 1..100 | 34 | 49 | |
P/E GROWTH RATING 1..100 | 89 | 100 | |
SEASONALITY SCORE 1..100 | 18 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CRRTF's Valuation (57) in the null industry is in the same range as ECGS (78). This means that CRRTF’s stock grew similarly to ECGS’s over the last 12 months.
ECGS's Profit vs Risk Rating (80) in the null industry is in the same range as CRRTF (100). This means that ECGS’s stock grew similarly to CRRTF’s over the last 12 months.
CRRTF's SMR Rating (94) in the null industry is in the same range as ECGS (100). This means that CRRTF’s stock grew similarly to ECGS’s over the last 12 months.
CRRTF's Price Growth Rating (34) in the null industry is in the same range as ECGS (49). This means that CRRTF’s stock grew similarly to ECGS’s over the last 12 months.
CRRTF's P/E Growth Rating (89) in the null industry is in the same range as ECGS (100). This means that CRRTF’s stock grew similarly to ECGS’s over the last 12 months.
| CRRTF | ECGS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 58% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 47% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 54% | 2 days ago 74% |
| MACD ODDS (%) | 2 days ago 64% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 31% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 29% | 2 days ago 71% |
| Advances ODDS (%) | N/A | 5 days ago 77% |
| Declines ODDS (%) | N/A | 23 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 59% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 23% | 2 days ago 90% |
Advertisement
CRRTF and
Correlation & Price change
A.I.dvisor indicates that over the last year, CRRTF has been loosely correlated with LIFD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRRTF jumps, then LIFD could also see price increases.
| Ticker / NAME | Correlation To CRRTF | 1D Price Change % | ||
|---|---|---|---|---|
| CRRTF | 100% | N/A | ||
| LIFD - CRRTF | 34% Loosely correlated | N/A | ||
| SIGA - CRRTF | 21% Poorly correlated | -0.34% | ||
| ELTP - CRRTF | 7% Poorly correlated | -1.51% | ||
| CVSI - CRRTF | 7% Poorly correlated | -5.00% | ||
| ECGS - CRRTF | 5% Poorly correlated | +16.41% | ||
More | ||||
ECGS and
Correlation & Price change
A.I.dvisor tells us that ECGS and GRUSF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECGS and GRUSF's prices will move in lockstep.
| Ticker / NAME | Correlation To ECGS | 1D Price Change % | ||
|---|---|---|---|---|
| ECGS | 100% | +16.41% | ||
| GRUSF - ECGS | 14% Poorly correlated | N/A | ||
| CXXIF - ECGS | 7% Poorly correlated | +5.46% | ||
| ELTP - ECGS | 7% Poorly correlated | -1.51% | ||
| CRRTF - ECGS | 5% Poorly correlated | N/A | ||
| CTTH - ECGS | 4% Poorly correlated | -2.44% | ||
More | ||||